Hengyi Wu - Lung Hwa Independent Director
| 2424 Stock | TWD 76.20 1.00 1.30% |
Director
Hengyi Wu is Independent Director of Lung Hwa Electronics
| Phone | 886 2 2578 7775 |
| Web | https://www.lhsat.com |
Lung Hwa Management Efficiency
The company has return on total asset (ROA) of (0.2463) % which means that it has lost $0.2463 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.8597) %, meaning that it generated substantial loss on money invested by shareholders. Lung Hwa's management efficiency ratios could be used to measure how well Lung Hwa manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Zhisheng Chen | Elitegroup Computer Systems | N/A | |
| Jinsu Lu | Chaintech Technology Corp | N/A | |
| Fangyu Yang | Chaintech Technology Corp | N/A | |
| Zhenhua Wang | Elitegroup Computer Systems | N/A | |
| Zhifeng Wang | Chaintech Technology Corp | N/A | |
| Huijun Guo | Chaintech Technology Corp | N/A | |
| Bangui Jiang | Chaintech Technology Corp | N/A | |
| Bangzhi Wu | Elitegroup Computer Systems | N/A | |
| Bokang Fan | Chaintech Technology Corp | N/A | |
| Lixu Peng | Chaintech Technology Corp | N/A | |
| Yuming He | Elitegroup Computer Systems | N/A | |
| Liangzhao Lin | Elitegroup Computer Systems | N/A | |
| Wennan Zhan | Elitegroup Computer Systems | N/A | |
| Hanfei Lin | Elitegroup Computer Systems | N/A | |
| Jerry Fong | Elitegroup Computer Systems | N/A | |
| Zhongrong Gong | Elitegroup Computer Systems | N/A | |
Management Performance
| Return On Equity | -0.86 | |||
| Return On Asset | -0.25 |
Lung Hwa Electronics Leadership Team
Elected by the shareholders, the Lung Hwa's board of directors comprises two types of representatives: Lung Hwa inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Lung. The board's role is to monitor Lung Hwa's management team and ensure that shareholders' interests are well served. Lung Hwa's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Lung Hwa's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Yaxuan Wang, General Manager, Director | ||
| Youzheng Zheng, Head of Finance | ||
| Qingquan Dong, Independent Director | ||
| Guangxiang Wang, Chairman of the Board | ||
| Anming Shen, Chief Operating Officer | ||
| Mingxiang Yang, Chief Technology Officer | ||
| Hengyi Wu, Independent Director | ||
| KuanMing Lin, Director | ||
| Quantai Bai, Deputy General Manager-Product Development, Director | ||
| Junxiong Fang, Head of Finance and Accounting | ||
| Puhuai Zheng, Chief Marketing Officer | ||
| Yalin Wang, Director |
Lung Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Lung Hwa a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.86 | |||
| Return On Asset | -0.25 | |||
| Operating Margin | (3.87) % | |||
| Current Valuation | 859.82 M | |||
| Shares Outstanding | 48.52 M | |||
| Shares Owned By Insiders | 69.61 % | |||
| Price To Earning | (23.53) X | |||
| Price To Book | 3.25 X | |||
| Price To Sales | 14.67 X | |||
| Revenue | 13.11 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Lung Stock Analysis
When running Lung Hwa's price analysis, check to measure Lung Hwa's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lung Hwa is operating at the current time. Most of Lung Hwa's value examination focuses on studying past and present price action to predict the probability of Lung Hwa's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lung Hwa's price. Additionally, you may evaluate how the addition of Lung Hwa to your portfolios can decrease your overall portfolio volatility.